Dermatitis - atopic and Photophobia

Summary:

Photophobia is found among people with Dermatitis - atopic, especially for people who are female, 30-39 old.

The study analyzes which people have Photophobia with Dermatitis - atopic. It is created by eHealthMe based on reports of 49 people who have Dermatitis - atopic from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 1,969 drugs and 1,975 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

What is Photophobia?

Photophobia (extreme sensitivity to light) is found to be associated with 1,288 drugs and 1,832 conditions by eHealthMe. Check the latest studies of Photophobia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

49 people who have Dermatitis - Atopic and Photophobia are studied.

Would you have Photophobia when you have Dermatitis - atopic?

Gender of people who have Dermatitis - Atopic and experienced Photophobia *:

female: 73.33 %
male: 26.67 %

Age of people who have Dermatitis - Atopic and experienced Photophobia *:

Common co-existing conditions for these people *:

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 19 people, 38.78%
Asthma: 4 people, 8.16%
Itching: 3 people, 6.12%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 3 people, 6.12%
Stress And Anxiety: 3 people, 6.12%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 4.08%
Neurodermatitis (a skin disorder characterized by long lasting itching and scratching): 2 people, 4.08%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 2.04%
Eczema Infected (eczema due to bacterial infection or with bacterial infection): 1 person, 2.04%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 2.04%

Common drugs taken by these people *:

Common symptoms for these people *:

Headache (pain in head): 16 people, 32.65%
Rashes (redness): 15 people, 30.61%
Weakness: 11 people, 22.45%
Eye Irritation: 11 people, 22.45%
Eye Pain: 10 people, 20.41%
Lacrimation Increased: 9 people, 18.37%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 9 people, 18.37%
Conjunctivitis (pink eye): 9 people, 18.37%
Eye Pruritus (eye itching): 9 people, 18.37%
Vision Blurred: 8 people, 16.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Photophobia?

- Check whether Photophobia is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Dermatitis - atopic (61,311 reports)
Photophobia (21,346 reports)

All the drugs that are associated with Photophobia:

Photophobia (1,288 drugs)

All the conditions that are associated with Photophobia:

Photophobia (1,832 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Photophobia and Dermatitis - atopic, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.